BioCentury
ARTICLE | Clinical News

FGLL: Phase I data

May 23, 2005 7:00 AM UTC

Data from a Phase I trial in 24 healthy volunteers receiving intranasal administration showed 1 of 3 doses of FGLL was safe and well tolerated. ...